A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- AstraZeneca
- Study ID
- NCT06129864
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Locally Advanced Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 130 Years
- Healthy Volunteers
- Not accepted
Interventions
- volrustomig — DRUGvolrustomig
Study Details
The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who have not progressed after receiving definitive concurrent chemoradiotherapy (cCRT).
Key Dates
- Start date
- Dec 14, 2023
- Status verified
- May 2026
- Primary completion
- Apr 18, 2028
- Completion
- Sep 12, 2030
Study Design
- Enrollment
- 1,145 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Study ArmParticipants in this arm will receive volrustomig.
- No Intervention: Observation ArmPatients in this arm will undergo observation.
Primary Outcome Measure
Progression-Free Survival (PFS) in participants with unresected LA-HNSCC with PD-L1 expressing tumors [ Time Frame: Up to approximately 8 years ]
Central Contacts
- AstraZeneca Clinical Study Information Center1-877-240-9479
Locations (70)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35233 | - |
| Research Site | Phoenix | Arizona | 85028 | - |
| Research Site | Prescott Valley | Arizona | 86314 | - |
| Research Site | Springdale | Arkansas | 72762 | - |
| Research Site | Fountain Valley | California | 92708 | - |
| Research Site | Los Angeles | California | 90024 | - |
| Research Site | Orange | California | 92868 | - |
| Research Site | San Francisco | California | 94143 | - |
| Research Site | Santa Rosa | California | 95403 | - |
| Research Site | Whittier | California | 90602 | - |
| Research Site | Aurora | Colorado | 80045 | - |
| Research Site | Colorado Springs | Colorado | 80909 | - |
| Research Site | Lone Tree | Colorado | 80124 | - |
| Research Site | Washington D.C. | District of Columbia | 20037 | - |
| Research Site | Fort Myers | Florida | 33901 | - |
| Research Site | Gainesville | Florida | 32610 | - |
| Research Site | Miami | Florida | 33125 | - |
| Research Site | Palm Bay | Florida | 32909 | - |
| Research Site | West Palm Beach | Florida | 33401 | - |
| Research Site | Niles | Illinois | 60714 | - |
| Research Site | Des Moines | Iowa | 50309 | - |
| Research Site | Kansas City | Kansas | 66160 | - |
| Research Site | Louisville | Kentucky | 40202 | - |
| Research Site | Baton Rouge | Louisiana | 70817 | - |
| Research Site | Shreveport | Louisiana | 71101 | - |
| Research Site | Baltimore | Maryland | 21231 | - |
| Research Site | Bethesda | Maryland | 20817 | - |
| Research Site | Hyattsville | Maryland | 20782 | - |
| Research Site | Towson | Maryland | 21204 | - |
| Research Site | Upper Marlboro | Maryland | 20774 | - |
| Research Site | Boston | Massachusetts | 02215 | - |
| Research Site | Fairhaven | Massachusetts | 02719 | - |
| Research Site | Ann Arbor | Michigan | 48105 | - |
| Research Site | Ann Arbor | Michigan | 48109 | - |
| Research Site | Minneapolis | Minnesota | 55417 | - |
| Research Site | Columbia | Missouri | 65211 | - |
| Research Site | St Louis | Missouri | 63110 | - |
| Research Site | St Louis | Missouri | 63110 | - |
| Research Site | East Brunswick | New Jersey | 08816 | - |
| Research Site | Hackensack | New Jersey | 07601 | - |
| Research Site | New Brunswick | New Jersey | 08901 | - |
| Research Site | Albuquerque | New Mexico | 87108 | - |
| Research Site | New York | New York | 10065 | - |
| Research Site | New York | New York | 10075 | - |
| Research Site | Stony Brook | New York | 11794 | - |
| Research Site | Charlotte | North Carolina | 28204 | - |
| Research Site | Winston-Salem | North Carolina | 27157 | - |
| Research Site | Cleveland | Ohio | 44106 | - |
| Research Site | Portland | Oregon | 97213 | - |
| Research Site | Portland | Oregon | 97239 | - |
| Research Site | Philadelphia | Pennsylvania | 19107 | - |
| Research Site | Pittsburgh | Pennsylvania | 15261 | - |
| Research Site | York | Pennsylvania | 17403 | - |
| Research Site | Sioux Falls | South Dakota | 57104 | - |
| Research Site | Sioux Falls | South Dakota | 57105 | - |
| Research Site | Nashville | Tennessee | 37212 | - |
| Research Site | Austin | Texas | 78745 | - |
| Research Site | Dallas | Texas | 75251 | - |
| Research Site | Flower Mound | Texas | 75028 | - |
| Research Site | Houston | Texas | 77030 | - |
| Research Site | Odessa | Texas | 79761 | - |
| Research Site | Tyler | Texas | 75702 | - |
| Research Site | Salt Lake City | Utah | 84112 | - |
| Research Site | West Jordan | Utah | 84088 | - |
| Research Site | Fairfax | Virginia | 22031 | - |
| Research Site | Norfolk | Virginia | 23502 | - |
| Research Site | Richmond | Virginia | 23230 | - |
| Research Site | Spokane | Washington | 99204 | - |
| Research Site | Tacoma | Washington | 98405 | - |
| Research Site | Tacoma | Washington | 98415 | - |
Find similar trials in Birmingham, AL
Related Studies
- Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerPHASE1 · Recruiting · National Cancer Institute (NCI) · Tampa, Florida
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Mayo Clinic · Jacksonville, Florida
- Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and NeckPHASE1 · Enrolling By Invitation · Krzysztof Misiukiewicz · New York, New York
- [18F]-AraG PET Imaging in LA HNSCCEARLY_PHASE1 · Not Yet Recruiting · Indiana University · Indianapolis, Indiana